Following Digitek Recall, Class Action Suits have been filed
At least two class action suits have been filed on behalf of individuals who used the heart drug Digitek (digoxin). The suits come less than three weeks after all lots of Digitek were recalled on April 25th when it was discovered that some tablets sold over the past year could be twice as thick as is appropriate and contain double the approved amount of active ingredient.
Digitek is a medication approved for treatment of heart failure and abnormal heart rhythms, such as atrial fibrillation. The recall applied to generic forms of digitalis manufactured by Icelandic drug maker Actavis Totowa, a division of Actavis Group. The drug was sold in the United States by Mylan Pharmaceuticals, Inc. under the “Bertek” brand and by UDL Laboratories, Inc. under the “UDL” brand.
Exposure to excessive amounts of digitalis may increase the risk of a condition known as digitalis toxicity. This could cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia or death. The risk of this serious illness is greatest among those with renal failure or impaired kidney function, which could even include those who are dehydrated.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The Digitek class action suits allege that Actavis, Mylan and UDL were negligent in allowing pills with twice the approved level of active ingredients to be sold. The plaintiffs claim that drug makers knew or had reason to know that Digitek was defective since at least 2006 and failed to warn of the dangers that could accelerate the risk of Digitalis toxicity.
On behalf of all individuals who were prescribed Digitek, the lawsuits attempt to establish the following classes:
- Digitek Refund Class: For those who purchased the heart drug.
- Digitek Personal Injury Class: For those who suffered adverse effects.
- Digitek Medical Monitoring Class: To provide medical screening, services, research and a registry to assure those who took Digitek receive prompt and proper medical treatment if needed.
In addition to the class action claims, it is expected that hundreds of people who suffered severe side effects from the double dose tablets will file individual Digitek lawsuits in the coming months.
Federal Digitek Lawsuits Consolidated in Southern District of West Virginia : AboutLawsuits.comAugust 19, 2008 at 3:23 pm
[...] Recall LawsuitsDigitek Lawsuits Filed in West Virginia as a Result of Double Strength TabletsFollowing Digitek Recall, Class Action Suits have been filedActavis Recalls Over 65 Generic Drugs Made at NJ Plant Motion Filed to Consolidate West Virginia [...]
"*" indicates required fields
More Top Stories
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.